Sign Up to like & get
recommendations!
1
Published in 2021 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofab466.731
Abstract: Abstract Background SARS-CoV-2 monoclonal antibodies (SMA) have demonstrated efficacy in treatment of early, mild to moderate COVID-19 in patients at high risk for progression to severe COVID-19. We created an SMA infusion clinic at a…
read more here.
Keywords:
cov monoclonal;
sars cov;
treatment;
patients receive ... See more keywords